Assistant Professor of Medicine, University of Ottawa
Division of Medical Oncology
Dr. Ong is staff Medical Oncologist who specializes in Genitourinary Malignancies (Prostate, Bladder, Testes, Renal), Malignant Melanoma, and Experimental Therapeutics. His training has included Undergraduate Medicine in Ottawa, Internal Medicine and Medical Oncology residency at Western, and further fellowship training in Experimental Therapeutics at the Royal Marsden Hospital in London UK before being recruited to The Ottawa Hospital Cancer Centre.
Dr. Ong’s research interests primarily include development of anticancer drug combination strategies including immunotherapy and targeted therapies, dose-optimization and sequencing-optimization of currently developed therapeutics, and development of non-invasive biomarker strategies. Dr. Ong is the lead investigator for a number of clinical trials locally for bladder and prostate cancers, and the main investigator for novel experimental therapeutics for genitourinary cancers and melanoma in Ottawa.
Nationally, Dr. Ong is an active member of the Investigational New Drug Executive Committee of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG), as well as the Canadian Cancer Clinical Trials Network (3CTN) Genitourinary Cancer Strategy Group. Locally, Dr. Ong is an active member of the Clinical Research Evaluation Committee (CREC), Research Ethics Board (REB), Department of Medicine Resident Research Working Group, and he is the Director of Resident Research for the Medical Oncology Residency Program.
Dr. Ong is an active tennis player, runner, and jazz musician, and spends his spare time enjoying the company of his wife and 2 children.
Education and Training
Doctor of Medicine, University of Ottawa
Internal Medicine, University of Western Ontario
Medical Oncology and Clinical Pharmacology, University of Western Ontario
Experimental Therapeutics, Royal Marsden Hospital
Publication search at PubMed (may contain inaccuracies)